Families USA commented on the Trump Administration’s proposed “public charge” rule. Under the administration’s proposal, immigrants could be considered a public charge, and therefore denied entry to the country or denied the right to adjust status and become a lawful permanent resident, if they receive Medicaid or certain other public benefits for a period of time.
Families USA, Community Catalyst, and over 45 national organizations representing health care stakeholders sent this letter to Congressional leadership, urging them to heed the strong message sent by the midterm elections and pursue an agenda that ensures the best health and health care are equally accessible and affordable to all. On November 6, voters from across the country and from all walks of life voted for high quality and affordable health care.
On September 7, the Trump administration took another step toward eliminating basic protections for immigrant children and their families who enter the U.S. without documentation—including those legally seeking asylum, by issuing a notice of proposed rulemaking (proposed regulation) that would dismantle constitutional protections for children established by the Flores Settlement Agreement governing the detention and treatment of children in U.S. immigration custody.
Millions of seniors and people with disabilities rely on Medicare for their health care, but it does not cover their oral health care. Even if someone needs dental care in order to have a medical procedure—like a kidney transplant patient who needs an oral infection treated to begin surgery -- Medicare won’t cover the oral health care.
41 Consumer and Patient Groups Urge the Trump Administration to Take Real Action on Prescription Drugs
Families USA, Public Citizen, and 39 other national and state-based organizations including the Services Employees International Union, the National Partnership for Women and Families, the AFL-CIO, AFSCME, and NETWORK Lobby for Catholic Social Justice submitted a comment letter in response to the Request for Information (RFI) from the Trump Administration regarding HHS’ Blueprint on Prescription Drug Costs.